Subscription Information

Dear Dynamic Wealth Report Reader, Just a quick heads-up… We here at DWR put our heads together and decided to dramatically reduce the price of membership to Biotech Supertrader. You see, it's always been the mission of Robert Morris, the editor, to get his incredibly valuable research into the hands of as many investors as possible.  This special pricing will allow him to make this happen. Your subscription includes all the trade alerts, all the regular updates, and access to the members only website.  All the same as before but at about a 40% discount! As you may know, Robert is one of the best small-cap biotech researchers in the world and we are proud to have him onboard here at DWR.  He is an expert at uncovering tiny biotech companies about to unveil new products or release positive results from their FDA drug approval process.  And he does it before anyone else learns about it. THAT is how his recommendations can make you spectacular profits! Click here to get all the details. If you are thinking of joining, now would be a good time to do it while the special 40% discount pricing is available.  It's the lowest we've ever offered on Biotech Supertrader. Good Investing! John Alexander, Editor Dynamic Wealth Report Copyright 2014 Hyperion Financial Group, LLC.  All Rights Reserved.  Protected by copyright laws of the United States and international treaties. This email may only be used pursuant to the subscription agreement controlling use of the Dynamic Wealth Report website and any reproduction, copying, or redistribution of this email or its contents, in whole or in part, is strictly prohibited without the express written permission of Hyperion Financial Group, LLC. LEGAL DISCLAIMER: Neither Hyperion Financial Group LLC nor any of it's employees, contractors or officers are registered investment advisors or a Broker/Dealer. As such, Hyperion Financial Group, LLC does not offer or provide personalized investment advice. Although Hyperion Financial Group, LLC employees and contractors may answer general customer service questions, they are not licensed under securities laws to address your particular investment situation. Nothing in this report, nor any communication by our employees or contractors to you should be considered personalized investment advice. Owners and writers may have positions in the securities that are discussed. However, no associated employees or contractors may intentionally engage in any transaction that directly or indirectly competes with the interests of our subscribers. We accept no compensation from any companies mentioned in our reports. Past performance is no guarantee of future results. All information is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell any security. All opinions, analyses and information contained herein are based on sources believed to be reliable and written in good faith, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. Investments recommended in this publication should only be made after consulting with your financial advisor.

This message was sent to ignoble.experiment@arconati.us from: Hyperion Financial | 20701 N Scottsdale Rd, Ste 107-154 | Scottsdale, AZ 85255

Email Marketing by

Manage Your Subscription  |  Forward To a Friend